ArticleZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2026
[Misdiagnosis of a giant hepatic perivascular epithelioid cell tumor: A case report].
Article in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Perivascular epithelioid cell tumor (PEComa) is a rare mesenchymal neoplasm, and giant (maximum diameter is ≥10 cm) hepatic PEComa is even more uncommon. We report a case of giant hepatic PEComa that was preoperatively misdiagnosed as fibrolamellar hepatocellular carcinoma. The patient was a middle-aged woman who presented with upper abdominal discomfort and was admitted to Xiangya Hospital of Central South University on August 21, 2025, for evaluation of a hepatic space-occupying lesion. She had no history of chronic liver disease, and relevant laboratory tests showed no significant abnormalities. Multiple preoperative imaging modalities revealed a giant hepatic mass, which was initially diagnosed as fibrolamellar hepatocellular carcinoma. The tumor was completely resected (the size of mass was 14.3 cm×13.5 cm×10.0 cm) and the final diagnosis of hepatic PEComa was established by histopathological examination and immunohistochemical analysis. During a 6-month postoperative follow-up period, the patient remained asymptomatic and showed no evidence of recurrence. The diagnosis of hepatic PEComa is challenging because of its lack of specific clinical manifestations and characteristic imaging findings. Through retrospective analysis of this case, the causes of misdiagnosis were explored and the key points for differential diagnosis were summarized. This report aims to improve awareness of hepatic PEComa among clinicians and imaging specialists, provide additional references for preoperative imaging diagnosis, reduce the rate of misdiagnosis, optimize treatment decision-making, and ultimately improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.